A carregar...
α(1)-Antitrypsin deficiency · 5: Intravenous augmentation therapy: current understanding
The biochemical and clinical efficacy of intravenous augmentation therapy in α(1)-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1747086/ https://ncbi.nlm.nih.gov/pubmed/15282394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thx.2003.006544 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|